Treatment Outcome in Pediatric Acute Lymphoblastic Leukemia With Hyperleukocytosis in the Yeungnam Region of Korea: A Multicenter Retrospective Study

Journal of Pediatric Hematology/oncology
Kyung Mi ParkYoung Tak Lim

Abstract

Acute lymphoblastic leukemia (ALL) with hyperleukocytosis at diagnosis is associated with early morbidity and mortality due to complications of leukostasis. Of 535 pediatric ALL patients (January 2004 to December 2016 from the Yeungnam region of Korea), 72 (13.5%) patients with an initial white blood cell (WBC) count of ≥100×10/L were included in this study, of whom 38 patients had extreme hyperleukocytosis (WBC>200×10/L) at diagnosis. Fourteen patients (19.4%) had ≥1 early respiratory and neurologic complications during induction therapy. Relapse occurred in 8 patients (24.2%) with extreme hyperleukocytosis and in 1 patient (3.0%) with an initial WBC count of 100 to 200×10/L (P=0.012). Estimated 10-year event-free survival rate (EFS) and overall survival rate were 78.3%±8.4% and 82.6%±7.7%, respectively. The 10-year EFS was significantly lower in patients with an initial WBC count of >200×10/L than in those with an initial WBC count of 100 to 200×10/L (65.7%±13.4% vs. 91.2%±7.9%; P=0.011). The 10-year EFS and overall survival rate did not differ significantly between patients with extreme hyperleukocytosis who received hematopoietic stem cell transplantation and those who received chemotherapy. In conclusion, pediatric ALL wit...Continue Reading

References

Sep 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H S MaurerG D Hammond
Sep 24, 2004·British Journal of Haematology·Mitchell S Cairo, Michael Bishop
Nov 18, 2004·Pediatric Blood & Cancer·Eric J LoweJohn T Sandlund
Jan 24, 2007·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Prakash SatwaniMitchell S Cairo
Nov 17, 2010·European Journal of Haematology·Goda VaitkevičienėUNKNOWN Nordic Society of Paediatric Haematology and Oncology (NOPHO)
Jan 23, 2016·Journal of Pediatric Hematology/oncology·Oussama AblaAhmed Naqvi
Jan 29, 2016·Current Treatment Options in Oncology·Antonio RuggieroRiccardo Riccardi
Feb 27, 2018·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Serdal Korkmaz
Nov 16, 2018·South Asian Journal of Cancer·Rachana ChennamaneniLakshmi Srinivas
Jul 10, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rob PietersMaria Grazia Valsecchi

❮ Previous
Next ❯

Citations

Mar 22, 2021·Journal of Hematology & Oncology·Zixi HongLiang Shao

❮ Previous
Next ❯

Methods Mentioned

BETA
leukapheresis
prophylactic

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.